A neuroblastoma-selective suicide gene therapy approach using the tyrosine hydroxylase promoter.
about
INSM1 promoter-driven adenoviral herpes simplex virus thymidine kinase cancer gene therapy for the treatment of primitive neuroectodermal tumorsFrontiers in Suicide Gene Therapy of Cancer.Gene therapy as a potential tool for treating neuroblastoma-a focused review.Targeted expression of human folylpolyglutamate synthase for selective enhancement of methotrexate chemotherapy in osteosarcoma cells.Expression mediated by three partial sequences of the human tyrosine hydroxylase promoter in vivo.
P2860
A neuroblastoma-selective suicide gene therapy approach using the tyrosine hydroxylase promoter.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
A neuroblastoma-selective suic ...... tyrosine hydroxylase promoter.
@en
type
label
A neuroblastoma-selective suic ...... tyrosine hydroxylase promoter.
@en
prefLabel
A neuroblastoma-selective suic ...... tyrosine hydroxylase promoter.
@en
P2093
P2860
P921
P1433
P1476
A neuroblastoma-selective suic ...... tyrosine hydroxylase promoter
@en
P2093
Anke Sandquist
Christiane Lex
Christof M Kramm
Susanne Frank
Ute Fischer
P2860
P304
P356
10.1203/01.PDR.0000132666.23103.EF
P407
P577
2004-06-04T00:00:00Z
P6179
1010378189